Neurology | MDPile

Cumulus Neuroscience Presents Groundbreaking Alzheimer's Study at AAIC 2024
7/18/2024
Cumulus Neuroscience Presents Promising Alzheimer's Study at AAIC 2024
7/18/2024
Revolutionary Stem Cell Treatment for Muscular Dystrophy Moves Forward
7/18/2024
FDA Greenlights New Treatment for Chronic Back Pain
7/17/2024
FDA Approves Revolutionary AI Software SubtleSYNTH™ for Faster MRI Scans
7/17/2024
FDA Greenlights New Stem Cell Treatment for Muscular Dystrophy
7/17/2024
FDA Greenlights Phase III Trial for New Lumbar Disc Therapy
7/17/2024
New Device Shows Promise in Treating Chronic Migraine
7/17/2024
New Compact Brain Imaging Tool Cleared by FDA to Revolutionize Diagnostics
7/16/2024
FDA Greenlights Phase III Trials for Promising Back Pain Therapy
7/16/2024
Leqembi: A New Hope for Early Alzheimer's Patients in Israel
7/12/2024
New AI Test Could Detect Alzheimer's Early with Innovate UK Funding
7/11/2024
New AI Test Aims to Revolutionize Early Alzheimer's Detection
7/11/2024
New Study Shows Better Results with Combined Cervical Fusion Technique
7/11/2024
New Hope for Alzheimer's Patients: Leqembi Approved in Hong Kong
7/11/2024
New Study Confirms Circumferential Cervical Fusion's Superiority for Severe Neck Degeneration
7/11/2024
New Juice-Based Probiotic Shows Hope for Multiple Sclerosis Management
7/11/2024
Promising New Cell Therapy Shows Hope for Chronic Back Pain Relief
7/10/2024
New Hope for ALS Patients: Higher Dose BRAVYL Treatment Shows Promise
7/8/2024
New Narcolepsy Treatment Shows Promise in Clinical Trials
7/8/2024
Innovative Research Uses AI to Detect Early Signs of Dementia During Sleep
7/2/2024
Cutting-edge Robotic System 'SPINDLE' Promises New Hope For Patients with Tremors
6/28/2024
New Developments in Parkinson’s Treatment: ND0612 Takes the Stage
6/28/2024
Breakthrough Treatment for Muscle Weakness Disorder Resubmitted for Approval in China
6/27/2024
Innovative Collaborations in Longevity Research: A Step Towards Healthier Aging
6/27/2024
Ensuring Ethical Standards in AI-Powered Clinical Trials: New Guidelines Ahead
6/27/2024
New Insights into Brain Stimulation: Neurophet's Innovative Research on Alzheimer's Disease
6/27/2024
New Insights into Cognitive Abilities in Children with Aicardi Goutières Syndrome
6/26/2024
New Hope for Alzheimer's: Xanamem Shows Promise Against Cognitive Decline
6/26/2024
New Hope for Multiple Sclerosis: Clinical Trials Begin for Bryostatin-1
6/26/2024
FDA Confirms WAKIX as Safe and Effective for Daytime Sleepiness in Narcolepsy
6/25/2024
New Horizons in Parkinson's Treatment: iRegene's Groundbreaking Trial Approved by US FDA
6/24/2024
Promising Advances in Rett Syndrome Treatment with CNM-Au8
6/21/2024
Vivoryon Therapeutics: Pioneering Small Molecule Advances at 2024 AGM
6/21/2024
Breakthrough Brain Stimulation Device Offers New Hope for Alzheimer's and Dementia Patients
6/20/2024
Advances in Neurologic Therapies: Avenue Therapeutics' Highlights
6/20/2024
Innovative Treatment for Parkinson’s: ClearPoint Neuro Partners with Aspen Neuroscience
6/20/2024
New Hope for Stiff Person Syndrome: FDA Clears Breakthrough CAR T-Cell Therapy for Trial
6/20/2024
Innovative Biodegradable Screws Revolutionize Bone Fracture Healing
6/19/2024
New ALS Treatment Shows Promise in Reducing Disease Progression
6/19/2024
Revolutionizing CNS Disorders Treatment: Cerevance's Groundbreaking Research at FENS Forum 2024
6/18/2024
Breakthroughs in Treating Rare Neurological Diseases: Cerevance’s Innovative Research at FENS 2024
6/18/2024
New Hope for Severe Stiff-Person Syndrome: KYV-101 Shows Promising Results
6/18/2024
New Navigation System Enhances Precision in Spinal Fusion Surgeries
6/13/2024
FDA Greenlights First Generic Deflazacort for Duchenne Muscular Dystrophy
6/12/2024
New Hope for Muscular Dystrophy: Clenbuterol in Phase 1 Clinical Trial
6/12/2024
Capricor Moves Closer to FDA Approval for Duchenne Muscular Dystrophy Treatment
6/11/2024
FDA Panel's Green Light Brings New Alzheimer’s Treatment Closer to Reality
6/11/2024
Breakthrough Epilepsy Treatment: LRP-661 Shows Promising Results in Pre-Clinical Trials
6/10/2024
Innovative Biotech Advances: Join Longeveron's Virtual Presentation on Regenerative Medicine
6/10/2024
Innovative Device Shows Promise in Alleviating Parkinson's Symptoms
6/7/2024
New Therapeutic Hope for Muscular Dystrophy: Epic Bio's EPI-321
6/7/2024
Innovative Patch Promises Better Alzheimer's Care for Japanese Patients
6/6/2024
New in ALS: Latest Findings from RADICAVA® (Edaravone) Research Highlighted at ENCALS 2024
6/5/2024
FDA's Fast-Track Gene Therapy Brings New Hope for Canavan Disease
6/5/2024
Cutting-Edge Drug Accelerator Set to Revolutionize Angelman Syndrome Treatment
6/4/2024
New Doses for Austedo XR Revolutionize Treatment Options for Movement Disorders
6/3/2024
How AI is Revolutionizing Multiple Sclerosis Diagnosis and Treatment
6/1/2024
Neurophet Showcases AI Solutions for Brain Disease at BIO USA 2024
5/31/2024
Impact of Sleep on Adolescent Cognitive Health with Higher Body Fat
5/30/2024
Breakthrough Treatment Approved for Genetic Form of ALS in Europe
5/30/2024
Vanda Pharmaceuticals Steps Up in the Fight Against Multiple Sclerosis
5/30/2024
FDA Approves Increased Dosage for First-Ever LEMS Treatment, FIRDAPSE®
5/30/2024
Jazz Pharmaceuticals Unveils Groundbreaking Advances in Sleep Disorder Treatments at SLEEP 2024
5/30/2024
FDA Greenlights Once-Daily Deutetrabenazine for Movement Disorders
5/30/2024
New FDA Approval: Simplified Treatment for Tardive Dyskinesia and Huntington's Disease Chorea
5/29/2024
New Insights in Neurodegenerative Therapy: Alterity's Latest Findings and What They Mean for Clinical Trials
5/29/2024
New Data Shows Cladribine’s Remarkable Impact on Multiple Sclerosis Progression
5/29/2024
Breakthrough RNA Therapy Shows Promise for Muscular Dystrophy Patients
5/29/2024
How Ofatumumab Benefits Multiple Sclerosis Patients of All Ethnicities
5/29/2024
Challenges in Approving Masitinib for ALS Treatment: What You Need to Know
5/29/2024
Unlocking New Frontiers in Migraine Treatment: Highlights from AHS 2024
5/29/2024
Promising Results for Stroke Drug CIRARA: A Hope for Severe Stroke Survivors
5/29/2024
New Advances in MS Treatment: Subcutaneous Ocrelizumab Offers Promising Results
5/28/2024
Altamira Therapeutics Enhances RNA Delivery Stability: Key Developments and Future Plans
5/28/2024
Promising New Therapy for a Rare Neurological Disorder Fast Tracked by FDA
5/28/2024
Breaking Barriers in Brain-Computer Interfaces: A New World Record
5/28/2024
Breakthrough in Pediatric Neurology: Neuren's NNZ-2591 Shows Promise for Pitt Hopkins Syndrome
5/27/2024
New Insights from Viltolarsen's Phase 3 Trial in Duchenne Muscular Dystrophy
5/27/2024
Balancing Act: Andexanet and Its Impact on Brain Hemorrhage Treatment
5/27/2024
Promising Treatment for Pitt Hopkins Syndrome Shows Significant Improvement in Children
5/27/2024
All About the 2024 CMSC Annual Meeting: What You Need to Know
5/26/2024
Sneak Peek into Cutting-Edge MS Research at the 2024 CMSC Annual Meeting
5/26/2024
New Phase 3 Study Highlights Eplontersen's Benefits for Nerve Damage
5/23/2024
New Hope for Fragile X Syndrome: FDA Approves Promising Drug SPG601
5/22/2024
Extended Studies Show Promise for ALZ-801 in Fighting Early Alzheimer's
5/22/2024
Switching to Inebilizumab Shows Promising Results in Preventing NMOSD Relapses
5/22/2024
Advancing Dementia Care: How Diverse Datasets and AI Can Drive Equity
5/21/2024
Promising New Treatment for Angelman Syndrome Shows Positive Results
5/21/2024
New Guidelines for Pregnant Women with Epilepsy: Ensuring Healthy Moms and Babies
5/21/2024
New Hope in Alzheimer's Treatment: LM11A-31 Shows Promise in Early Trials
5/21/2024
How Brain Lesions Might Trigger Takotsubo Syndrome (Broken Heart Syndrome)
5/21/2024
New Advances in Treating NMOSD: Transitioning from Rituximab to Inebilizumab
5/20/2024
New PET Tracer APN-1607 Gains Fast Track Status for Rare Brain Disorder Diagnosis
5/20/2024
New Hope for Cervical Dystonia Patients: Introducing Daxxify
5/20/2024
Innovative Drug Delivery for Parkinson's: New Hope for Patients
5/20/2024
Innovative Treatments for NMOSD: Balancing Safety, Efficacy, and Cost
5/20/2024
Navigating the Best Treatment for Neuromyelitis Optica: A Look at Safety, Efficacy, and Cost
5/20/2024
New Hope for Children with Duchenne Muscular Dystrophy: FDA Grants Special Status to AOC 1044
5/20/2024
New Phase 1 Study Begins Testing Promising Alzheimer’s Treatment
5/17/2024
Eisai Advances in Alzheimer's Treatment with New Subcutaneous Injection
5/15/2024
Long-Term Study Reveals Insights on Rozanolixizumab for CIDP Treatment
5/15/2024
Ravulizumab Emerges as Leading Treatment for Preventing NMOSD Relapse
5/14/2024
Breakthrough Combination Therapy Treats Rare Neurological Disorders
5/14/2024
Successful Treatment for Rare Combination of CIDP and NMOSD with Corticosteroids and Immunosuppressants
5/14/2024
Understanding the Relationship Between Prenatal Antiseizure Medications and Autism Risk
5/14/2024
Understanding the Risks of Anti-Seizure Medications During Pregnancy: Autism Spectrum Disorder Insights
5/14/2024
Revolutionizing SMA Treatment: Upcoming Promises from the RESILIENT Study
5/13/2024
Understanding the Role of Serum Neurofilament Light in Tracking Multiple Sclerosis Progress
5/13/2024
Understanding Spasmodic Dysphonia: Insights into the Neurological Disorder Affecting Voices
5/13/2024
Revolutionary Alzheimer’s Treatment Shows Promise in Slowing Biological Aging
5/13/2024
Alkermes Advances Narcolepsy Treatment with Promising Phase 2 Trial of ALKS 2680
5/13/2024
Emerging Alzheimer's Treatment Bezisterim Shows Promise in Delaying Aging
5/12/2024
Exploring the Link Between Basal Ganglia Function and Sleep Disorders in Parkinson's Disease
5/11/2024
Unlocking the Mystery of Rapid Cerebellar Ataxia: The Role of Anti-DAGLA Autoantibodies
5/11/2024
Advancing Treatment for Myotonic Dystrophy: A Closer Look at AOC 1001's Breakthrough Designation
5/11/2024
Exploring the Impact of Omega-3 on Child Cognitive and Emotional Development
5/11/2024
Advancements in Myotonic Dystrophy Type 1 Treatment with AOC 1001
5/11/2024
Revolutionizing Healthcare: Topcon and Microsoft's AI Eye Screening Collaboration
5/10/2024
Exploring the Efficacy of Lidocaine Injections for Youth Migraine Relief
5/10/2024
Exploring the Link Between Depression and Parkinson's Disease Progression
5/10/2024
Exploring the Link Between Massage Guns and Vertigo in Younger Adults
5/10/2024
Understanding Neurocysticercosis: A Comprehensive Overview
5/10/2024
Setback in Migraine Prevention: AEON Biopharma's ABP-450 Fails to Outperform Placebo
5/10/2024
Exploring the Unique Impact of the APOE4 Gene Variant on Alzheimer's Disease
5/10/2024
Advancements in Essential Tremor Treatment: Insights from the KINETIC Phase 2 Trial
5/9/2024
Exploring the Impact of Olive Oil on Dementia Mortality: A Comprehensive Study
5/9/2024
Enhanced Recovery in ICH Patients Through Surgical Intervention: Insights from the ENRICH Trial
5/9/2024
Exploring the Impact of Negative Myoclonus in Progressive Myoclonus Ataxia
5/9/2024
Racial Disparities in Myasthenia Gravis Experiences and Concerns
5/9/2024
Exploring the Unique Impact of APOE4 on Alzheimer's Disease Progression
5/9/2024
Exploring Parasomnias: From REM Behavior Disorder to Sleepwalking
5/9/2024
Exploring the Impact of PrimeC on ALS Progression in High-Risk Patients
5/8/2024
Exploring the Impact of Food Additives on Mental Health
5/8/2024
Exploring the Safety of Losmapimod in Treating Facioscapulohumeral Muscular Dystrophy
5/8/2024
Upcoming FDA Advisory Committee Review of Donanemab for Alzheimer's
5/8/2024
Exploring the Pharmacokinetic Profile of STS101 in a Crossover Study
5/8/2024
Advancements in Myotonic Dystrophy Treatment: The Launch of a New Phase 3 Trial for AMO-02
5/8/2024
Understanding Tardive Dyskinesia Among Antipsychotic Users in the U.S.
5/6/2024
Expanded Access Program for Foralumab in Progressive Multiple Sclerosis
5/5/2024
Exploring New Frontiers in Cardiac Therapy for Friedreich Ataxia
5/4/2024
Exploring the New Frontiers in Parkinson's Disease Treatment with ANPD001 Cell Therapy
5/4/2024
Exploring the Connection Between Leptin Levels and Alzheimer's Disease Progression
5/4/2024
Revolutionizing Tardive Dyskinesia Management: The Introduction of Valbenazine Sprinkle Formulation
5/2/2024
New Advances in Alzheimer's Treatment: A Closer Look at ALZ-801's Clinical Trials
5/2/2024
Revolutionizing Dementia Care: The Promise of AI-Enhanced Neurotechnology
5/1/2024
New Advances in Treatment Options for Tardive Dyskinesia and Huntington's Disease
5/1/2024
The Impact of Stress on Political Beliefs and Decision-Making
4/29/2024

...

Terms & Conditions